REQUEST A DEMO
Total
USD $0.00
Search more companies

Genommalab Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Genommalab Ecuador S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Genommalab Ecuador S.A. is an enterprise located in Ecuador, with the main office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on July 26, 2005. 21 (2023) employees currently work for Genommalab Ecuador S.A.. From the latest financial highlights, Genommalab Ecuador S.A. reported a net sales revenue increase of 6.83% in 2023. During that time, Genommalab Ecuador S.A.’s total assets grew by 1.79%. In, 2023, the company’s net profit margin increased by 4.43%.

Headquarters
Av. Jose Santiago Castillo, Kennedy Business Bldg. , Floor 402
Guayaquil; Guayas;

Contact Details: Purchase the Genommalab Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Genommalab Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Genommalab Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Genommalab Ecuador S.A. report to view the information.
Incorporation Date:
July 26, 2005
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Genommalab Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
6.83%
Total operating revenue
6.88%
Operating profit (EBIT)
-31.17%
EBITDA
-30.74%
Net Profit (Loss) for the Period
50.95%
Total assets
1.79%
Total equity
50.24%
Operating Profit Margin (ROS)
-15.16%
Net Profit Margin
4.43%
Return on Equity (ROE)
0.47%
Debt to Equity Ratio
-204.76%
Quick Ratio
-0.99%
Cash Ratio
-0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?